Royalty Pharma (RPRX) Interest Coverage Ratio Growth (1y) (2020 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) Interest Coverage Ratio Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.91 Bn | 45.24 Bn | 4.68 Bn | 3.24% |
| 2 | Royalty Pharma | 36.78 Bn | 38.89 Bn | - | -53.46% |
| 3 | Royal Gold | 22.19 Bn | 22.06 Bn | 390.45 Mn | -69.56% |
| 4 | OR Royalties | 6.98 Bn | 6.91 Bn | 82.22 Mn | 36.44% |
| 5 | Encore Capital | 2.06 Bn | 1.88 Bn | 455.04 Mn | 24.06% |
| 6 | Atlanticus Holdings | 1.41 Bn | 853.17 Mn | 686.46 Mn | -17.23% |
| 7 | Jefferson Capital | 1.23 Bn | 1.21 Bn | - | -20.08% |
| 8 | Upbound | 1.11 Bn | 1.00 Bn | 594.84 Mn | 19.52% |
| 9 | Lufax Holding | 1.08 Bn | -1.19 Bn | - | 233.51% |
| 10 | Metalla Royalty & Streaming | 957.79 Mn | 946.72 Mn | 4.75 Mn | 1,653.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -53.46% |
| Mar 31, 2026 | -26.61% |
| Dec 31, 2025 | -24.98% |
| Sep 30, 2025 | -51.43% |
| Jun 30, 2025 | -44.46% |
| Mar 31, 2025 | 590.76% |
| Dec 31, 2024 | -57.61% |
| Sep 30, 2024 | 235.96% |
| Jun 30, 2024 | 3.79% |
| Mar 31, 2024 | -116.35% |
| Dec 31, 2023 | 226.18% |
| Sep 30, 2023 | -19.59% |
| Jun 30, 2023 | -34.11% |
| Mar 31, 2023 | 118.52% |
| Dec 31, 2022 | -414.73% |
| Sep 30, 2022 | -40.15% |
| Jun 30, 2022 | -59.59% |
| Mar 31, 2022 | -23.82% |
| Dec 31, 2021 | -60.65% |
| Sep 30, 2021 | -57.89% |